Cargando…
Rapamycin maintains the primordial follicle pool and protects ovarian reserve against cyclophosphamide-induced damage
Any abnormal activation of primordial follicles and subsequent depletion can irreversibly diminish the ovarian reserve, which is one of the major chemotherapy-induced adverse effects in young patients with cancer. Herein, we investigated the effects of rapamycin on the activation and development of...
Autores principales: | CHEN, Xiuying, TANG, Zhijing, GUAN, Haiyun, XIA, Hexia, GU, Chao, XU, Yan, LI, Bin, ZHANG, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Society for Reproduction and Development
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334315/ https://www.ncbi.nlm.nih.gov/pubmed/35718464 http://dx.doi.org/10.1262/jrd.2022-001 |
Ejemplares similares
-
Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo
por: Zhou, Linyan, et al.
Publicado: (2017) -
Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression
por: Feng, Juan, et al.
Publicado: (2022) -
The impact of oocyte death on mouse primordial follicle formation and ovarian reserve
por: Umeno, Ken, et al.
Publicado: (2022) -
Identification of Biomarkers for Predicting Ovarian Reserve of Primordial Follicle via Transcriptomic Analysis
por: Liu, Li, et al.
Publicado: (2022) -
LKB1 acts as a critical gatekeeper of ovarian primordial follicle pool
por: Jiang, Zong-Zhe, et al.
Publicado: (2015)